John Charles Thomas, EVP, General Counsel at Krystal Biotech, sold KRYS on Jun 25, 2026
Data as of Oct 16
▼ SELL$347K1,000 shares at $347.27John Charles Thomas EVP, General CounselKRYS Krystal Biotech, Inc.
- Traded
- Jun 25, 2026
- Disclosed
- Jun 26, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KRYS since disclosure
−15.0%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund
Change in closing price from Jun 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.